Reaction
Optical Coherence Tomography Abnormal reporting signals
As of the last recalculation, Optical Coherence Tomography Abnormal appears in 648 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is FARICIMAB (PRR 18,227.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Faricimab | 568 | 18,227.7 | 19,610.1 |
| Aflibercept | 38 | 41.5 | 41.5 |
| Bevacizumab | 89 | 26.6 | 26.6 |
| Ranibizumab | 17 | 21.1 | 21.1 |